Functionalized Carriers for Receptor Blocking and Targeted Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing technologies face challenges in effectively preventing and minimizing the spread of pathogens such as coronaviruses, influenzas, and other disease-causing agents, as current vaccines and medications often require significant development time, have limited efficacy, and can cause side effects, while pathogens exploit host receptors for entry and replication, leading to unmet needs for proactive, targeted interventions.
Innovation Solution
Development of nano- and micromaterial-based carriers that mimic pathogen surface features to competitively inhibit binding to host receptors, deliver targeted drugs, and stimulate immune responses, using inhalation devices and other delivery methods to block pathogen entry and replication.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional vaccines and medications are used to prevent and treat pathogen infections, then therapeutic efficacy is achieved, but development time is significant and side effects occur
Solution Approach 1:
The patent applies preliminary action by using carriers that preemptively block pathogen binding sites on host cells before infection occurs. The carriers are designed to occupy receptors such as ACE2 on host cells, preventing pathogens like SARS-CoV-2 from attaching and entering cells. This proactive approach eliminates the need for lengthy vaccine development and clinical trials, providing immediate protection upon administration.
2Reliability
If conventional medications are used to treat pathogen infections, then therapeutic effects are achieved, but side effects are caused
Solution Approach 1:
The patent applies local quality by designing carriers with specific functional groups that selectively bind to pathogen-receptor interfaces. The carriers are functionalized with molecules that mimic pathogen binding sites, allowing them to selectively block pathogen attachment to specific host cell receptors without affecting other physiological processes. This targeted approach provides therapeutic effect while minimizing systemic side effects.
3Reliability
If carriers are designed to mimic pathogen surface features for competitive inhibition, then pathogen binding is blocked, but device complexity increases
Solution Approach 1:
The patent applies copying by creating carriers that replicate key surface features of pathogens, such as viral spike proteins or bacterial surface molecules. These copied features are incorporated into the carrier structure to enable competitive binding with host receptors. By copying only the essential binding interfaces rather than entire pathogens, the design achieves pathogen blocking functionality while maintaining manageable structural complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances therapeutic efficacy by reducing pathogen binding and replication, minimizing disease spread with minimal side effects, and providing immune stimulation through targeted drug delivery and receptor blocking.
Implementation Method 1
synthesized to minimize the spread of pathogens and infectious agents... by competitive inhibition
Implementation Method 2
Once carriers bind to host cells, they can enter said host cells (e.g., by endocytosis)
Data Source
AI summary
According to some embodiments, a method of providing treatment of a host comprises binding a carrier to cell structures of cells of the host to reduce a likelihood of an agent binding to said cell structures to at least partially inhibits the agent from binding to said cell structures, wherein the carrier comprises a core and a surface functionalized on the core, wherein the functionalized surface bind to target areas of cell structures of the host's cells, and wherein the carrier is to be used as targeted treatment for one or more disease, infections or allergic reactions caused by a disease-causing agent or source.